These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 32058078)

  • 1. Computational modeling of cardiac growth and remodeling in pressure overloaded hearts-Linking microstructure to organ phenotype.
    Niestrawska JA; Augustin CM; Plank G
    Acta Biomater; 2020 Apr; 106():34-53. PubMed ID: 32058078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An updated Lagrangian constrained mixture model of pathological cardiac growth and remodelling.
    Guan D; Zhuan X; Luo X; Gao H
    Acta Biomater; 2023 Aug; 166():375-399. PubMed ID: 37201740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction.
    Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T
    Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single strain-based growth law predicts concentric and eccentric cardiac growth during pressure and volume overload.
    Kerckhoffs RC; Omens J; McCulloch AD
    Mech Res Commun; 2012 Jun; 42():40-50. PubMed ID: 22639476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired Myofilament Contraction Drives Right Ventricular Failure Secondary to Pressure Overload: Model Simulations, Experimental Validation, and Treatment Predictions.
    Philip JL; Pewowaruk RJ; Chen CS; Tabima DM; Beard DA; Baker AJ; Chesler NC
    Front Physiol; 2018; 9():731. PubMed ID: 29997518
    [No Abstract]   [Full Text] [Related]  

  • 6. Contractile Adaptation of the Left Ventricle Post-myocardial Infarction: Predictions by Rodent-Specific Computational Modeling.
    Mendiola EA; Neelakantan S; Xiang Q; Merchant S; Li K; Hsu EW; Dixon RAF; Vanderslice P; Avazmohammadi R
    Ann Biomed Eng; 2023 Apr; 51(4):846-863. PubMed ID: 36394778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling of cardiac growth and remodeling of myofiber orientation.
    Bovendeerd PH
    J Biomech; 2012 Mar; 45(5):872-81. PubMed ID: 22169149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A homogenized constrained mixture model of cardiac growth and remodeling: analyzing mechanobiological stability and reversal.
    Gebauer AM; Pfaller MR; Braeu FA; Cyron CJ; Wall WA
    Biomech Model Mechanobiol; 2023 Dec; 22(6):1983-2002. PubMed ID: 37482576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure.
    Li J; Yousefi K; Ding W; Singh J; Shehadeh LA
    Cardiovasc Res; 2017 May; 113(6):633-643. PubMed ID: 28453726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiscale simulations of left ventricular growth and remodeling.
    Sharifi H; Mann CK; Rockward AL; Mehri M; Mojumder J; Lee LC; Campbell KS; Wenk JF
    Biophys Rev; 2021 Oct; 13(5):729-746. PubMed ID: 34777616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodeling.
    Andenæs K; Lunde IG; Mohammadzadeh N; Dahl CP; Aronsen JM; Strand ME; Palmero S; Sjaastad I; Christensen G; Engebretsen KVT; Tønnessen T
    PLoS One; 2018; 13(7):e0201422. PubMed ID: 30052659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologic versus pathologic hypertrophy and the pressure-overloaded myocardium.
    Weber KT; Clark WA; Janicki JS; Shroff SG
    J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S37-50. PubMed ID: 2485029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions Between Structural Remodeling and Hypertrophy in the Right Ventricle in Response to Pulmonary Arterial Hypertension.
    Avazmohammadi R; Mendiola EA; Li DS; Vanderslice P; Dixon RAF; Sacks MS
    J Biomech Eng; 2019 Sep; 141(9):0910161-09101613. PubMed ID: 31260516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Exercise-Induced Myocardium Growth Using Finite Element Modeling and Bayesian Optimization.
    Fan Y; Coll-Font J; van den Boomen M; Kim JH; Chen S; Eder RA; Roche ET; Nguyen CT
    Front Physiol; 2021; 12():694940. PubMed ID: 34434115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Fibrosis in the Pressure Overloaded Left and Right Ventricle as a Therapeutic Target.
    Schimmel K; Ichimura K; Reddy S; Haddad F; Spiekerkoetter E
    Front Cardiovasc Med; 2022; 9():886553. PubMed ID: 35600469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac-specific overexpression of catalase identifies hydrogen peroxide-dependent and -independent phases of myocardial remodeling and prevents the progression to overt heart failure in G(alpha)q-overexpressing transgenic mice.
    Qin F; Lennon-Edwards S; Lancel S; Biolo A; Siwik DA; Pimentel DR; Dorn GW; Kang YJ; Colucci WS
    Circ Heart Fail; 2010 Mar; 3(2):306-13. PubMed ID: 20018955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice.
    Sakata Y; Hoit BD; Liggett SB; Walsh RA; Dorn GW
    Circulation; 1998 Apr; 97(15):1488-95. PubMed ID: 9576430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical modeling of cardiac growth and remodeling.
    Lee LC; Kassab GS; Guccione JM
    Wiley Interdiscip Rev Syst Biol Med; 2016 May; 8(3):211-26. PubMed ID: 26952285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose transporter 4-deficient hearts develop maladaptive hypertrophy in response to physiological or pathological stresses.
    Wende AR; Kim J; Holland WL; Wayment BE; O'Neill BT; Tuinei J; Brahma MK; Pepin ME; McCrory MA; Luptak I; Halade GV; Litwin SE; Abel ED
    Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1098-H1108. PubMed ID: 28822962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.